Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 98739

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 02, 2026
Product types
Device
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
DFI Co., Ltd.

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 7

One Step 10A in vitro diagnostic test

Z-2082-2026
Recall number
Z-2082-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
6533 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI: 08806141303497/ Lot: 241023, 250305, 250415, 250527, 250625, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 2 of 7

One Step UTI in vitro diagnostic test REF: 3374

Z-2083-2026
Recall number
Z-2083-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
2423 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI: 08806141303480/ Lot: 241023, 250625, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 3 of 7

One Step pH in vitro diagnostic test REF: 31I4P

Z-2084-2026
Recall number
Z-2084-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
7860 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI: 08806141303060/ Lot: 250305, 250415, 250509, 250625, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 4 of 7

QUCARE Total Cholesterol in vitro diagnostic test REF: 6407

Z-2085-2026
Recall number
Z-2085-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
6398 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI: 08806141303060/ Lot: BS032501, BS042502, BS062501, BS062502, BS082501

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 5 of 7

Uric Acid in vitro diagnostic test REF: 31H0P

Z-2086-2026
Recall number
Z-2086-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
59815 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI: 08806141303077/ Lot: 241023, 250415, 250509, 250617, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 6 of 7

One Step K in vitro diagnostic test REF: 81A4

Z-2087-2026
Recall number
Z-2087-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
761 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI:08806141302650/ Lot: 241023, 250625, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

device · product 7 of 7

One Step P in vitro diagnostic test REF: 8194

Z-2088-2026
Recall number
Z-2088-2026
Initiated
April 02, 2026
Classification
Class II
Status
Ongoing
Recalling firm
DFI Co., Ltd.
Quantity
1064 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
The devices were distributed without required FDA premarket clearance or approval.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

No Marketing Application

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Code information

UDI:08806141302025/ Lot: 241023, 250527, 250905

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.